Home › Research › Health systems and care delivery
Downstream Revenue Generated After Visits to Neurologists: A Claims-Based Analysis of Medicare Data
Esper Gregory J, Muthukumar Lavanya, Lee Reynolds Evan, Hill Chloe E, Lin Chun Chieh, Belsinger Laura, Cooper Kristin, Callaghan Brian C. Neurology. Clinical practice, 2025-08-11
Topic: Risk, prevention and care in population studies
To determine downstream revenue of neurologists compared with nonneurologists after incident diagnostic visits by analysis of Medicare claims. Neurologist attributable reimbursement was minimal compared with reimbursement for other specialties when accounting for all revenues. Compared with nonneurologists, neurologists guide diagnostic evaluation and treatment generating significantly greater downstream revenue after the incident diagnosis of 5 neurologic disorders including MS, PD, epilepsy or other seizures, dementia, and autoimmune neuromuscular conditions. These findings underscore the clinical and financial worth of neurologists to health systems providing specialty and subspecialty care for neurologic disorders.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Esper Gregory, J., Lavanya, M., Evan, L. R., Hill Chloe, E., Chieh, L. C., Laura, B., et al. (2025). Downstream Revenue Generated After Visits to Neurologists: A Claims-Based Analysis of Medicare Data. Neurology. Clinical practice. https://doi.org/10.1212/cpj.0000000000200487
Vancouver
Esper Gregory J, Lavanya M, Evan LR, Hill Chloe E, Chieh LC, Laura B, et al. Downstream Revenue Generated After Visits to Neurologists: A Claims-Based Analysis of Medicare Data. Neurology. Clinical practice. 2025. doi:10.1212/cpj.0000000000200487. PMID: 40787285.
BibTeX
@article{espergregory2025-40787285,
author = {Esper Gregory, J. and Lavanya, Muthukumar and Evan, Lee Reynolds and Hill Chloe, E. and Chieh, Lin Chun and Laura, Belsinger and Kristin, Cooper and Callaghan Brian, C.},
title = {{Downstream Revenue Generated After Visits to Neurologists: A Claims-Based Analysis of Medicare Data}},
journal = {Neurology. Clinical practice},
year = {2025},
doi = {10.1212/cpj.0000000000200487},
pmid = {40787285},
url = {https://doi.org/10.1212/cpj.0000000000200487}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- To determine downstream revenue of neurologists compared with nonneurologists after incident diagnostic visits by analysis of Medicare claims.
- Neurologist attributable reimbursement was minimal compared with reimbursement for other specialties when accounting for all revenues.
- Compared with nonneurologists, neurologists guide diagnostic evaluation and treatment generating significantly greater downstream revenue after the incident diagnosis of 5 neurologic disorders including MS, PD, epilepsy or other seizures, dementia, and autoimmune neuromuscular conditions.
- These findings underscore the clinical and financial worth of neurologists to health systems providing specialty and subspecialty care for neurologic disorders.
Why it matters
In Medicare claims, patients first diagnosed with one of five neurologic conditions (MS, Parkinson's disease, epilepsy or other seizures, dementia, and autoimmune neuromuscular conditions) generated "significantly greater downstream revenue" when a neurologist guided their evaluation and treatment rather than a nonneurologist. The neurologists' own share of reimbursement was described as "minimal" compared with other specialties. This is a billing analysis with no dementia-only result reported here. It says nothing about whether patients did better, and it is not evidence about treating or preventing Alzheimer's disease.
Study details
- Evidence strengthLow
How this study scored 40/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Neurology. Clinical practice) |
| Journal's citation record | 0 / 4 | Neurology Clinical Practice: journal h-index 60 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-17) |
| Citations per year | 0 / 5 | 0.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 6 / 6 | Cited by 380 other studies in this library |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Brian Christopher Callaghan: h-index 54 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Michigan: institution h-index 2,222 (OpenAlex) |
| Multi-centre collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40787285) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 40 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
417 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Health systems and care delivery
Also in Health systems and care delivery
172 studies in the library are filed under Health systems and care delivery with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Health systems and care delivery hub.